Sutro Biopharma News

Piper Sandler Trims Price Target on Sutro Biopharma to $11 From $12, Maintains Overweight Rating

MT NewswiresApr 4 00:00

Sutro Biopharma Analyst Ratings

BenzingaApr 3 20:21

Piper Sandler Keeps Their Buy Rating on Sutro Biopharma (STRO)

TipRanksApr 3 19:06

Sutro Biopharma Buy Rating Justified by Strategic Partnerships and Promising Pipeline

TipRanksApr 3 12:35

Sutro Biopharma Analyst Ratings

BenzingaMar 28 19:42

Oppenheimer Maintains Outperform on Sutro Biopharma, Maintains $10 Price Target

BenzingaMar 28 19:43

Analysts Are Bullish on Top Healthcare Stocks: Sutro Biopharma (STRO), Catalyst Pharma (CPRX)

TipRanksMar 27 19:50

Sutro Biopharma Analyst Ratings

BenzingaMar 27 19:40

Oppenheimer Maintains Outperform on Sutro Biopharma, Maintains $10 Price Target

BenzingaMar 27 19:41

Sutro Biopharma's New Forum Selection Clause: Protecting Interests or Alienating Shareholders?

TipRanksMar 27 14:00

Wedbush Adjusts Sutro Biopharma's Price Target to $8 From $12, Maintains Outperform Rating

MT NewswiresMar 26 19:13

Sutro Biopharma Analyst Ratings

BenzingaMar 26 18:09

Sutro Biopharma: A Stable Hold Amid Pipeline Execution and Short-Term Uncertainties

TipRanksMar 26 16:47

Sutro Biopharma Buy Rating Affirmed on Strong Financials and Promising Clinical Pipeline

TipRanksMar 26 12:25

TD Cowen Sticks to Its Buy Rating for Sutro Biopharma (STRO)

TipRanksMar 26 10:15

Sutro Biopharma: A Balanced Hold Rating Amid Pipeline Execution and Upcoming Data Catalysts

TipRanksFeb 29 19:29

Analysts Offer Insights on Healthcare Companies: Codexis (CDXS), Leap Therapeutics (LPTX) and Sutro Biopharma (STRO)

TipRanksJan 23 04:50

Sutro Biopharma: Hold Rating Maintained Amid Near-Term Uncertainties and Market Potential Ambiguities

TipRanksJan 8 18:06

Buy Rating Justified: Sutro Biopharma's Luvelta Shows Promise in PROC Treatment and Beyond

TipRanksJan 5 19:27

Buy Rating for Sutro Biopharma: Promising Clinical Developments and Strategic Financial Strength

TipRanksDec 12, 2023 13:25